ロード中...
Advances in new drug therapies for the management of sickle cell disease
INTRODUCTION: Sickle cell disease (SCD) is an orphan disease in the United States, but is highly prevalent worldwide. Only two drugs, hydroxyurea and L-glutamine, are approved for this disease. With an improved understanding of the pathophysiology of SCD as well as the success of several recently ap...
保存先:
| 出版年: | Expert Opin Orphan Drugs |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6411095/ https://ncbi.nlm.nih.gov/pubmed/30873300 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21678707.2018.1471983 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|